Lin JF - Search Results

1

Growth-differentiation factor-15 and major cardiac events.

Lin JF, Wu S, Hsu SY, Yeh KH, Chou HH, Cheng ST, Wu TY, Hsu WT, Yang CC, Ko YL. Lin JF, et al. Am J Med Sci. 2014 Apr;347(4):305-11. doi: 10.1097/MAJ.0b013e318291cd4e. Am J Med Sci. 2014. PMID: 24521768

2

A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers.

Yeh KH, Cheng AL, Lin MT, Hong RL, Hsu CH, Lin JF, Chang KJ, Lee PH, Chen YC. Yeh KH, et al. Among authors: lin mt, lin jf. Anticancer Res. 1997 Sep-Oct;17(5B):3867-71. Anticancer Res. 1997. PMID: 9427794 Clinical Trial.

3

High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers.

Yeh KH, Lin MT, Lin DT, Tang JL, Lui LT, Lin JF, Chang YS, Cheng AL, Yu SC, Chang KJ, Chen YC. Yeh KH, et al. Among authors: lin mt, lin dt, lin jf. Breast Cancer Res Treat. 1998 Jun;49(3):237-44. doi: 10.1023/a:1006023731381. Breast Cancer Res Treat. 1998. PMID: 9776507

4

High dose tamoxifen plus cisplatin and etoposide in the treatment of patients with advanced, inoperable nonsmall cell lung carcinoma.

Yang CH, Cheng AL, Yeh KH, Yu CJ, Lin JF, Yang PC. Yang CH, et al. Among authors: lin jf. Cancer. 1999 Aug 1;86(3):415-20. doi: 10.1002/(sici)1097-0142(19990801)86:3<415::aid-cncr9>3.0.co;2-h. Cancer. 1999. PMID: 10430249 Clinical Trial.

5

Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer.

Yeh KH, Lu YS, Hsu CH, Lin JF, Chao HJ, Huang TC, Chung CY, Chang CS, Yang CH, Cheng AL. Yeh KH, et al. Among authors: lin jf. Br J Cancer. 2005 Mar 28;92(6):1013-8. doi: 10.1038/sj.bjc.6602469. Br J Cancer. 2005. PMID: 15770209 Free PMC article. Clinical Trial.

6

Resveratrol reduces infarct size and improves ventricular function after myocardial ischemia in rats.

Lin JF, Lin SM, Chih CL, Nien MW, Su HH, Hu BR, Huang SS, Tsai SK. Lin JF, et al. Among authors: lin sm. Life Sci. 2008 Aug 29;83(9-10):313-7. doi: 10.1016/j.lfs.2008.06.016. Epub 2008 Jun 27. Life Sci. 2008. PMID: 18639559

7

Association of matrix metalloproteinase 9 genotypes and cardiovascular disease risk factors with serum matrix metalloproteinase 9 concentrations in Taiwanese individuals.

Wu S, Hsu LA, Teng MS, Lin JF, Chang HH, Chang PY, Hu CF, Ko YL. Wu S, et al. Among authors: lin jf. Clin Chem Lab Med. 2010 Apr;48(4):543-9. doi: 10.1515/CCLM.2010.099. Clin Chem Lab Med. 2010. PMID: 20184534

8

Data feedback reduces door-to-balloon time in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Lin JF, Hsu SY, Wu S, Liau CS, Chang HC, Liu CJ, Huang HL, Ho YT, Weng SL, Ko YL. Lin JF, et al. Heart Vessels. 2011 Jan;26(1):25-30. doi: 10.1007/s00380-010-0030-3. Epub 2010 Oct 27. Heart Vessels. 2011. PMID: 20978899

9

Right ventricular function in patients with different infarction sites after a first acute myocardial infarction.

Hsu SY, Lin JF, Chang SH. Hsu SY, et al. Among authors: lin jf. Am J Med Sci. 2011 Dec;342(6):474-9. doi: 10.1097/MAJ.0b013e3182198686. Am J Med Sci. 2011. PMID: 21681077

10

Resveratrol protects left ventricle by increasing adenylate kinase and isocitrate dehydrogenase activities in rats with myocardial infarction.

Lin JF, Wu S, Huang SS, Lu BY, Lin SM, Tsai SK. Lin JF, et al. Among authors: lin sm. Chin J Physiol. 2011 Dec 31;54(6):406-12. doi: 10.4077/CJP.2011.AMM097. Chin J Physiol. 2011. PMID: 22229508

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

504 results

Search Page